NOVELIX PHARMACEUTICALS
Smallcap | BSE
Sector
Here's the live share price of Novelix Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.75₹ 0.40
As on May 18, 2026, 04:01 PM IST
Novelix Pharmaceuticals Price Performance
Today's LowToday's High
₹51.00₹57.00
₹53.65
52 Weeks' Low52 Weeks' High
₹27.94₹70.16
₹53.65
Open Price
₹54.00
Prev. Close
₹53.25
Volume
2,114
Novelix Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Novelix Pharmaceuticals | -1.65 | -8.15 | -14.84 | -15.70 | 92.02 | 73.91 | 39.60 |
| Sun Pharmaceutical Industries | 3.13 | 12.52 | 12.09 | 8.02 | 9.81 | 26.45 | 22.63 |
| Divi's Laboratories | 1.63 | 8.27 | 10.80 | 4.53 | 8.55 | 27.64 | 11.02 |
| Torrent Pharmaceuticals | 0.32 | 5.73 | 3.14 | 15.13 | 34.61 | 39.37 | 26.02 |
| Cipla | 5.85 | 15.91 | 5.22 | -7.14 | -4.87 | 15.66 | 10.12 |
| Dr. Reddy's Laboratories | 2.79 | 8.85 | 4.73 | 6.81 | 8.03 | 13.75 | 4.83 |
| Mankind Pharma | 3.17 | 18.97 | 20.27 | 11.54 | -2.50 | 22.61 | 11.95 |
| Lupin | -5.46 | -3.37 | 1.24 | 9.57 | 8.69 | 41.70 | 13.59 |
| Zydus Lifesciences | 5.57 | 5.54 | 8.92 | 6.09 | 9.77 | 24.31 | 10.14 |
| Aurobindo Pharma | 0.73 | 8.17 | 26.54 | 21.19 | 24.76 | 32.67 | 8.39 |
| Laurus Labs | 7.95 | 17.49 | 31.04 | 29.82 | 120.13 | 61.51 | 22.93 |
| Biocon | 11.98 | 21.57 | 12.07 | 1.15 | 25.52 | 20.08 | 2.01 |
| Glenmark Pharmaceuticals | -1.11 | 3.93 | 15.10 | 25.32 | 61.54 | 56.72 | 31.08 |
| Alkem Laboratories | -2.14 | -1.98 | -0.42 | -4.64 | 4.53 | 16.93 | 12.85 |
| Abbott India | 4.51 | 7.74 | 5.86 | -5.87 | -8.82 | 9.60 | 11.42 |
| Anthem Biosciences | 1.27 | 9.93 | 15.41 | 19.39 | 8.78 | 2.85 | 1.70 |
| Ipca Laboratories | 6.09 | 12.66 | 9.75 | 12.53 | 18.22 | 33.58 | 8.61 |
| GlaxoSmithKline Pharmaceuticals | -3.83 | -1.22 | -8.04 | -4.08 | -15.49 | 22.80 | 9.50 |
| Ajanta Pharma | 5.86 | 13.50 | 9.09 | 28.22 | 23.34 | 36.30 | 19.69 |
| Gland Pharma | 13.38 | 24.38 | 19.34 | 18.99 | 47.07 | 16.86 | -5.02 |
Over the last one year, Novelix Pharmaceuticals has gained 92.02% compared to peers like Sun Pharmaceutical Industries (9.81%), Divi's Laboratories (8.55%), Torrent Pharmaceuticals (34.61%). From a 5 year perspective, Novelix Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (22.63%) and Divi's Laboratories (11.02%).
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 53.94 | 53.81 |
| 10 | 54.27 | 54.22 |
| 20 | 54.89 | 54.68 |
| 50 | 55.04 | 55.54 |
| 100 | 57.37 | 55.22 |
| 200 | 52.24 | 50.25 |
Novelix Pharmaceuticals Share Holding Pattern
In the latest quarter, Novelix Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 50.57% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Novelix Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| May 06, 2026, 01:21 AM IST IST | Novelix Pharma. - Intimation Under Regulation 30 (LODR) Regulations, 2015- Website Address. |
| Apr 28, 2026, 11:51 PM IST IST | Novelix Pharma. - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Apr 09, 2026, 09:10 PM IST IST | Novelix Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 31, 2026, 08:42 PM IST IST | Novelix Pharma. - Announcement under Regulation 30 (LODR)-Allotment |
| Mar 31, 2026, 08:38 PM IST IST | Novelix Pharma. - Announcement under Regulation 30 (LODR)-Resignation of Director |
About Novelix Pharmaceuticals
Novelix Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/10/1993 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L67120TG1994PLC018956 and registration number is 018956. Currently Company is involved in the business activities of Manufacture of macaroni, noodles, couscous and similar farinaceous products. Company's Total Operating Revenue is Rs. 30.72 Cr. and Equity Capital is Rs. 9.95 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressAmrutha Estates, 6th floor, H.No. 3-6-237/610, Hyderabad Telangana 500029
- Contact
Management
- Mrs. Monam KapoorInd. Non-Executive Director
- Mr. Venkateshwarlu PulluruWhole Time Director
- Mr. Janardhan Das KabraInd. Non-Executive Director
- Mr. Gattu Gnana PrakashInd. Non-Executive Director
- Mr. Jivamohan Divakar ValluriNon Exe.Non Ind.Director
- Mr. Lakshman SamalaInd. Non-Executive Director
- Ms. Mayuri BaidyaInd. Non-Executive Director
FAQs on Novelix Pharmaceuticals Share Price
What is the share price of Novelix Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Novelix Pharmaceuticals is ₹53.65 as on May 18, 2026.
What kind of stock is Novelix Pharmaceuticals?
The Novelix Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Novelix Pharmaceuticals?
The market cap of Novelix Pharmaceuticals is ₹43.46 Cr as on May 18, 2026.
What are today's High and Low prices of Novelix Pharmaceuticals?
Today’s highest and lowest price of Novelix Pharmaceuticals are ₹57.00 and ₹51.00.
What are the 52 Week High and 52 Week Low of Novelix Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Novelix Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Novelix Pharmaceuticals is ₹70.16 and 52-week low of Novelix Pharmaceuticals is ₹27.94 as on May 18, 2026.
How has the Novelix Pharmaceuticals performed historically in terms of returns?
The Novelix Pharmaceuticals has shown returns of 0.75% over the past day, -8.15% for the past month, -14.84% over 3 months, 92.02% over 1 year, 73.91% across 3 years, and 39.6% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Novelix Pharmaceuticals?
P/E ratio of and PB ratio of Novelix Pharmaceuticals are -18.80 and 5.87 on May 18, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse